Overview

A Study to Assess the Effect of Food With Fezolinetant in Healthy Female Participants

Status:
Completed
Trial end date:
2021-02-17
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of food on the pharmacokinetics of a single oral dose of fezolinetant under fasted and fed conditions in healthy female participants. The study will also evaluate the safety and tolerability of a single oral dose of fezolinetant under fasted and fed conditions in healthy female participants.
Phase:
Phase 1
Details
Lead Sponsor:
Astellas Pharma Global Development, Inc.